Aduhelm (aducanumab-avwa)
Order Form

Aduhelm

ADUHELM (aducanumab-avwa) is an amyloid beta-directed antibody indicated for the treatment of Alzheimer’s disease. Treatment with ADUHELM should be initiated in patients with mild cognitive impairment or mild dementia stage of disease.

For more information, please refer to the Aduhelm website, full Prescribing Information, and Medication Guide.

Note: Please speak with your healthcare provider for more information if you think this therapy might be right for you.

How do I make a referral or transition my treatment to Infusion Associates?

1. Ask your healthcare provider to fax us a completed order form for your medication, clinical notes, demographics and your insurance card to (616) 954-1675.

2. Providers can find order forms on our medications page.

3. One of our intake specialists will contact you to confirm receipt of your referral.

4. We will then verify benefits, obtain any required prior authorizations, and contact you to schedule an appointment.